TB 500

TB-500 is a synthetic heptapeptide derived from thymosin beta-4 that is investigated for promoting wound healing, tissue repair, and angiogenesis through actin-binding and cell migration mechanisms, though it remains an unapproved research compound without FDA authorization for human use.

Brief glance

The primary outcome is Recovery & Repair, but it's also used for Immune Support, Anti-Aging, Performance. This compound is considered a Peptide. It is also known as Thymosin Beta-4, TB-500. It may be compounded in 503A pharmacies where allowed. It is not listed under a DEA schedule.

Overview

TB-500 is a synthetic heptapeptide derived from the active fragment of thymosin beta-4, a naturally occurring peptide involved in cell migration, actin regulation, and tissue repair. The compound is currently classified as a research chemical and unapproved drug by the FDA, with no approved medical indications for human use. TB-500 appears on the World Anti-Doping Agency prohibited list and exists in a regulatory grey area, not qualifying as an FDA-approved pharmaceutical or lawful dietary supplement ingredient.

TB-500 is a synthetic heptapeptide corresponding to the N-acetylated active fragment (amino acids 17-23, Ac-LKKTETQ) of the endogenous peptide thymosin beta-4, a naturally occurring protein involved in tissue repair processes. As a pharmaceutical active ingredient, it functions primarily through regulation of actin polymerization, which supports cell migration, differentiation, and endothelial activity. Its basic pharmacology includes promotion of angiogenesis, keratinocyte migration, collagen deposition, and reduction of inflammation, contributing to wound healing and tissue regeneration. TB-500 has been explored in veterinary preparations and preclinical studies for accelerating recovery in injuries, though human clinical applications remain investigational.

Benefits

TB-500, a synthetic version of thymosin beta-4, promotes tissue repair and regeneration by enhancing cell migration, actin synthesis, and angiogenesis, which support faster healing of muscles, tendons, ligaments, and wounds.¹,²,³ It exhibits anti-inflammatory effects by modulating cytokine levels and immune responses, reducing swelling and pain associated with injuries, chronic conditions, and connective tissue damage.¹,²,⁴ Clinically, these properties have shown potential in accelerating recovery from injuries, post-surgical healing, and conditions like pressure ulcers in dermal trials, though it lacks broad regulatory approval as a pharmaceutical and is primarily investigational.²,³

Side effects

Common side effects of TB 500 include injection site reactions such as redness, swelling, pain, or irritation, along with transient fatigue, lethargy, headaches, dizziness, and occasional gastrointestinal discomfort like nausea.⁵,⁶,⁷ Rarer but more serious adverse effects may encompass flu-like symptoms, hypersensitivity reactions including pruritus, urticaria, warmth sensation, sweating, weakness, throat tightness, or severe anaphylaxis with risks of cardiovascular collapse, pulmonary edema, angioneurotic edema, cyanosis, and even death, particularly upon repeated administration.⁷,⁸ Key safety considerations involve its lack of FDA approval for human use, limited large-scale clinical trials leading to unknown long-term risks such as potential immune dysregulation, cancer promotion via growth factor modulation, downregulation of endogenous peptides, or drug interactions, necessitating use only under medical supervision with pharmaceutical-grade product and avoidance in those with hypersensitivity history or autoimmune conditions.⁴,⁶,⁸,⁹,¹⁰ Patients should discontinue use and seek immediate care for severe symptoms like fever, blistering, rash, vomiting, or hives.⁷

Mechanisms of action

TB-500, a synthetic version of thymosin beta-4, primarily acts by binding to and sequestering actin, a key protein comprising up to 10% of cellular proteins that forms the cytoskeleton essential for cell structure and movement.⁴,¹¹,¹²,¹³ This interaction modulates the equilibrium between globular G-actin and filamentous F-actin, promoting actin polymerization and depolymerization to facilitate cell migration toward injury sites.⁴,¹⁴,¹⁵ By enhancing endothelial and keratinocyte migration, it accelerates wound healing and tissue regeneration while upregulating actin to support cell proliferation and differentiation.¹¹,¹²,¹⁵ Additionally, TB-500 stimulates angiogenesis for improved nutrient delivery to damaged tissues and reduces inflammation and oxidative stress to foster a healing environment.⁴,⁵